Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia (Q73275289)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

title

Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

B-cell chronic lymphocytic leukemia

2 November 2019

main subject

1 reference

S Sivaraman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

P Venugopal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

R Ranganathan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

C G Deshpande

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

X Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

A Jajeh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

S A Gregory

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

T O'Brien

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

H D Preisler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

Cytokines, Cellular & Molecular Therapy

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

81-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Isolated human follicular dendritic cells display a unique antigenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Phenotypic, morphologic changes and Ig secretion induced on B-NHL cells in vitro by interferon alpha and all-trans-retinoic acid: possible progression toward a more differentiated state

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13684730050515804

10.1080/13684730050515804

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108573 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference